Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply

Detalles Bibliográficos
Autores principales: Matsuda, Shogo, Yamamoto, Mahiro, Kotani, Takuya, Takeuchi, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter to the Editor (Matters arising from published papers)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019654/
https://www.ncbi.nlm.nih.gov/pubmed/35450277
http://dx.doi.org/10.1093/rap/rkac025
_version_ 1784689336630902784
author Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
author_facet Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
author_sort Matsuda, Shogo
collection PubMed
description
format Online
Article
Text
id pubmed-9019654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90196542022-04-20 Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply Matsuda, Shogo Yamamoto, Mahiro Kotani, Takuya Takeuchi, Tohru Rheumatol Adv Pract Letter to the Editor (Matters arising from published papers) Oxford University Press 2022-04-11 /pmc/articles/PMC9019654/ /pubmed/35450277 http://dx.doi.org/10.1093/rap/rkac025 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor (Matters arising from published papers)
Matsuda, Shogo
Yamamoto, Mahiro
Kotani, Takuya
Takeuchi, Tohru
Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title_full Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title_fullStr Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title_full_unstemmed Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title_short Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
title_sort comment on: combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. reply
topic Letter to the Editor (Matters arising from published papers)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019654/
https://www.ncbi.nlm.nih.gov/pubmed/35450277
http://dx.doi.org/10.1093/rap/rkac025
work_keys_str_mv AT matsudashogo commentoncombinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereportreply
AT yamamotomahiro commentoncombinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereportreply
AT kotanitakuya commentoncombinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereportreply
AT takeuchitohru commentoncombinationofimmunosuppressivetherapyandnintedanibimprovescapillaroscopicchangesinsystemicsclerosisinterstitiallungdiseaseacasereportreply

Ejemplares similares